Researchers from Boston-based Brigham and Women’s Hospital (BWH) are utilizing the CallAssure system from Vocantas Inc. (Ottawa) to assess the impact of automated telephone follow-up systems on the management of patients on commonly prescribed medications.
CallAssure uses voice response and speech technology to enable providers to evaluate real-time patient data. The system, which supports HL7 standards, automatically records any symptoms the patient is experiencing in a note which is then attached to the patient’s electronic record. Study researchers hope that this outreach can facilitate communication between patients and their physicians between visits to address potentially serious issues, according to the company.
The project is being led by Jennifer Haas, M.D., at BWH’s Division of General Medicine. Haas’ research has focused on the use of technology to improve the quality and safety of patient care, as well as access to care.
